Navigation Links
IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
Date:5/15/2008

l survival and quality of life benefits for patients treated with L-MTP-PE continue to be supported through physician experience and we remain committed to advancing L- MTP-PE through the European and U.S. regulatory processes to bring this important treatment to market."

Update on L-MTP-PE Regulatory Status

In January 2008 the Company announced that following presentation of data at an oral explanation hearing before the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency, the CHMP determined in a non-binding opinion that L-MTP-PE suggested a possible clinical benefit in terms of survival and granted the Company a clock stop, or time extension. The clock stop allows the Company additional time to respond to all the remaining questions regarding the marketing authorization application for L-MTP-PE (MAA). The CHMP has requested clarification of the existing data in order to gain assurance about the quality of the data before drawing any final conclusions from the data presented. In addition, the Company is required to address a number of remaining questions relating to chemistry, manufacturing and controls (CMC) and the Company expects to provide responses and data regarding these issues to the CHMP in advance of its meeting scheduled for June 23-26, although the CHMP may have additional questions or require additional information regarding these issues. In April, the European regulatory authorities conducted an inspection of the Children's Oncology Group (COG) to assess the quality of the overall survival data from the 2006 confirmatory database included in our applications for regulatory approval, and to review Good Clinical Practices compliance of COG in terms of patient randomization and stratification, overall survival data collection, and study monitoring. The Company supported the COG in this effort.

The Company expects to receive a final opinion from the CHMP in the third quarter and a final decision fro
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
2. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
3. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
4. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
5. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer
8. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
9. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
10. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
11. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... 18, 2013 Although colonoscopy exams prevent many ... most sensitive method for detecting colorectal cancers 2 , ... cases 3 . EndoChoice ® Inc. today unveiled ... improves the accuracy of this procedure and greatly reduces ... be discussing these clinical trial results and featuring the ...
(Date:5/18/2013)... YORK , May 18, 2013 ... law firm, is investigating potential securities fraud at ... AVEO). (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) ... Company and its executives violated federal securities laws ... the Company,s Phase III drug trials for Tivopath ...
(Date:5/17/2013)... -- Medical devices are any medical items that are ... of their different mechanisms, actions and regulatory requirements, medical ... drug trails due to their unique clinical practices. Currently, ... both safety and efficacy (which is left to the ... as the SFDA) evaluate MDs for both safety and ...
Breaking Medicine Technology:New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Statistical Challenges in Medical Device Trail Evaluation 2
... Show Individuals Reported Consistent Pain-Free,Results From Attack to ... who suffer from,migraines frequently cite inconsistent effectiveness as ... data from more,than 1,100 patients show that the ... results at two and,four hours, as well as ...
... NEW YORK--(BUSINESS WIRE)--May 2, 2007 - Pluristem Life ... the,commercialization of products for a variety of indications,announced ... at the,13th Annual Meeting of the International Society ... Australia., Pluristem CEO and Chairman, Mr. Zami Aberman ...
Cached Medicine Technology:Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across,Multiple Migraine Attacks 2Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across,Multiple Migraine Attacks 3Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across,Multiple Migraine Attacks 4Pluristem to Present Two Scientific Posters at the International,Society for Cellular Therapy 2Pluristem to Present Two Scientific Posters at the International,Society for Cellular Therapy 3
(Date:5/20/2013)... Los Angeles, CA (PRWEB) May 20, 2013 ... has just been released to the public creating ... to gain access to this elite business training. ... the course as well as an exclusive bonus. ... known for providing elite business training to individuals ...
(Date:5/20/2013)... May 20, 2013 According to a May ... at Indoor Tanning Salons,” tanning salons in the ... Food and Drug Administration wants to see cancer warnings on ... minimum age floor of eighteen for the use of indoor ... about melanoma, which has become increasingly common over the last ...
(Date:5/20/2013)... Salt Lake Community College’s Know Greater Heroes ... 25 winners for 2013. As part of the award, ... Heroes is a leadership training program that involves SLCC athletes ... to eat right, be active, and avoid drugs and alcohol. ... Heroes program each year, and visit more than 30 schools ...
(Date:5/20/2013)... The Muscular Dystrophy Association is ... for good at an Executive Lock-Up at Chima Brazilian ... , More than 100 “jailbirds” are expected to ... and families affected by muscle disease. Representatives from various ... realtors, doctors, attorneys, bankers, and members of the auto ...
(Date:5/20/2013)... Rockville, MD (PRWEB) May 20, 2013 ... announced the winners of the fourth annual Case ... professionals and organizations committed to ensuring the system ... Awards Program highlighted the innovative and creative work ... promoting wellness and ensuring safe transitions of care ...
Breaking Medicine News(10 mins):Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2Health News:Tanning - FDA Wants Tanning Salons to Post Cancer Warning Signs 2Health News:SLCC Know Greater Heroes Program Named to Select 25 2Health News:SLCC Know Greater Heroes Program Named to Select 25 3Health News:MDA to Put Fort Lauderdale Community Leaders Behind Bars for Good 2Health News:Dorland Health Announces the 2013 Case In Point Platinum Awards Winners 2
... ... ... ... , March 18 "A good night,s sleep" has long been the intention of millions of people suffering from sleep disorders around the world.  However, this objective is scarcely ...
... Tobacco Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... WASHINGTON , March 18 Kids in New Hampshire will take ...
... of employer-sponsored child care, early education, and work/life solutions, today announced that it has been named to the Center for Companies That Care Honor Roll for the third straight year. ... , ... ... ...
... Higher Tobacco Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... WASHINGTON , March 18 Kids in ...
... MINNEAPOLIS , March 18 ... one that both moms and kids can happily agree on. ... and is free of artificial colors, flavors and sweeteners.  It ... with low fat milk containing both calcium and vitamin D. ...
... Ill. March 18, 2010 Two new studies ... Third Eye Retroscope (TER), a retrograde viewing device, during ... standard colonoscopy detected 13.2 percent more polyps than colonoscopy ... second study examined endoscopist experience using TER and its ...
Cached Medicine News:Health News:Sleep Well, Stay Healthy: Good Quality and Restorative Sleep Are Essential for Better Mental and Physical Health 2Health News:Sleep Well, Stay Healthy: Good Quality and Restorative Sleep Are Essential for Better Mental and Physical Health 3Health News:Sleep Well, Stay Healthy: Good Quality and Restorative Sleep Are Essential for Better Mental and Physical Health 4Health News:New Hampshire Kids 'Kick Butts' on March 24 2Health News:New Hampshire Kids 'Kick Butts' on March 24 3Health News:New Hampshire Kids 'Kick Butts' on March 24 4Health News:Bright Horizons Honored as 'Company that Cares' for Third Straight Year 2Health News:Bright Horizons Honored as 'Company that Cares' for Third Straight Year 3Health News:Montana Kids 'Kick Butts' on March 24 2Health News:Montana Kids 'Kick Butts' on March 24 3Health News:Montana Kids 'Kick Butts' on March 24 4Health News:Montana Kids 'Kick Butts' on March 24 5Health News:New Simply...Go-Gurt Contains No High Fructose Corn Syrup, Artificial Flavors or Colors 2Health News:New Simply...Go-Gurt Contains No High Fructose Corn Syrup, Artificial Flavors or Colors 3Health News:Studies examine Third Eye Retroscope during colonoscopy 2Health News:Studies examine Third Eye Retroscope during colonoscopy 3Health News:Studies examine Third Eye Retroscope during colonoscopy 4Health News:Studies examine Third Eye Retroscope during colonoscopy 5
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTC/1Q chairs are recommended for ... clean room, static control, health care ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTC/1Q chairs are recommended for ... clean room, static control, health care ...
... with concave seats and standard-sized backrests ... like seats, backrests, armrests, and casters ... recommended for the following environments: industry, ... health care and office. • With ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With cast ...
Medicine Products: